Treatment May Increase Risk of Colorectal Cancer in Hodgkin Lymphoma Survivors
Hodgkin lymphoma patients treated with subdiaphragmatic radiation and/or procarbazine have an increased risk of developing colorectal cancer, a study suggests.
Diagnosis & Disease Information
Consolidation Regimen Deemed “Highly Active” in Relapsed/Refractory Hodgkin Lymphoma
Consolidation with up to 8 cycles of brentuximab vedotin plus nivolumab appears active in high-risk, relapsed/refractory Hodgkin lymphoma.
Pediatric Cancer Survivors Experience Premature Aging
Young adult survivors of pediatric cancer experience significant premature aging, a retrospective study suggests.
Adcetris Approved for Pediatric Patients With High-Risk Classical Hodgkin Lymphoma
The approval was based on data from the open-label phase 3 AHOD1331 trial.
Substituting Brentuximab Vedotin for Bleomycin Improves EFS in Pediatric Hodgkin Lymphoma
Brentuximab vedotin improved event-free survival but not overall survival.
Novel Inherited Variants May Raise Risk for Hodgkin Lymphoma
Researchers identified 44 Hodgkin lymphoma variants in 28 pedigrees, including a newly identified splice variant in KDR.
High Risk of Secondary Lung Cancer Seen in Hodgkin Lymphoma Survivors
Survivors of Hodgkin lymphoma may have a higher risk of developing lung cancer than former smokers, a study suggests.
Targeted Radiotherapy Remains Important in Pediatric Hodgkin Lymphoma With Slow Early Response to Chemotherapy
Researchers sought to assess the importance of radiotherapy in pediatric patients with early‐stage low-risk classical Hodgkin lymphoma.
Low Adoption of SC-RT for Lymphoma Among Medicare Beneficiaries
Researchers sought to determine the trends in the utilization of Medicare on short-course radiotherapy in patients with lymphoma.
CVD Mortality Leading Cause of Death for Stage I, II Hodgkin Lymphoma
The cumulative incidence of death due to cardiovascular disease exceeded the cumulative incidence of cancer-related death for almost all patients with stage I or II classic Hodgkin lymphoma.
- Loading...
Loading...
Loading... 
Loading...